메뉴 건너뛰기




Volumn 2, Issue 1, 2001, Pages 47-49

Menjugate Chiron

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CRM 197; MENINGOCOCCUS VACCINE; POLYSACCHARIDE; UNCLASSIFIED DRUG;

EID: 0035148285     PISSN: 09678298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (3)

References (16)
  • 5
    • 0006415637 scopus 로고    scopus 로고
    • Chiron and Canadian collaborators announce publication of promising phase II results for novel meningococcus C vaccine
    • 305836; November 17
    • (1998) Chiron Corp Press Release
  • 6
    • 0006414321 scopus 로고    scopus 로고
    • Chiron's meningitis vaccine positive in phase II
    • 313133
    • (1998) Bioworld Week , vol.6 , Issue.47 , pp. 4
  • 9
    • 0006481912 scopus 로고    scopus 로고
    • Chiron's meningitis C vaccine approved in UK - Company anticipates revenue of $100 million in the year 2000
    • 357897; March 01
    • (2000) Chiron Corp Press Release
  • 11
    • 0006489561 scopus 로고    scopus 로고
    • Chiron enters comarketing and copromotion agreement with Aventis Pasteur MSD for Menjugate, Fluad
    • 374760; July 14
    • (2000) Chiron Corp Press Release
  • 12
    • 0003189580 scopus 로고    scopus 로고
    • Aventis Pasteur MSD adds Chiron's Meng C and flu vaccines to portfolio
    • 376204
    • (2000) FDC Reports Pink Sheet , vol.62 , Issue.30 , pp. 23
  • 15
    • 0006414078 scopus 로고    scopus 로고
    • The UK and Ireland health authorities approve Menjugate for infant use; Menjugate meningococcal C meningitis vaccine approved for use in vaccinating infants older than 2 months of age
    • 385953; October 17
    • (2000) Chiron Corp Press Release


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.